IP Verse

Ipsen Pharma S.a.s. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ipsen Pharma S.a.s.

Patent Number:
EP3432916
Title:
Stabilized Non-Protein Clostridial Toxin Compositions
Applicant:
ALLERGAN, INC.
Opposition Date:
May 12, 2020
Patent Number:
EP3436054
Title:
Stabilized Non-Protein Clostridial Toxin Compositions
Applicant:
ALLERGAN, INC.
Opposition Date:
May 12, 2020
Patent Number:
EP2692350
Title:
Lyophilized Preparation Of Botulinum Toxin
Applicant:
MEDY-TOX INC.
Opposition Date:
Feb 2, 2018

Latest patents of Ipsen Pharma S.a.s. opposed by its competitors

Patent:
EP2957278
Grant Date:
May 17, 2017
Title:
A Stable Composition Comprising Pthrp And Uses Thereof
Oppositions:
2
Patent:
EP2249847
Grant Date:
Apr 12, 2017
Title:
Novel Method For Preparing Extracts Of Ginkgo Biloba
Oppositions:
1

Competitors of Ipsen Pharma S.a.s.

ALLERGAN, INC.

DR. WILLMAR SCHWABE GMBH & CO. KG

ISENBRUCK BOSL HORSCHLER LLP

Want to track Ipsen Pharma S.a.s.?

Feel free to send us a message here and we will get back to you